Dengjun Sun

机构：Qingdao University, Yuhuangding Hospital

发表论文 18 篇 · 总被引 315 次 · h-index 8

代表论文

• Microwave ablation plus chemotherapy versus chemotherapy in advanced non-small cell lung cancer: a multicenter, randomized, controlled, phase III clinical trial (2020 · European Radiology · 被引 75)
• Lx2-32c, a novel semi-synthetic taxane, exerts antitumor activity against prostate cancer cells in vitro and in vivo (2016 · Acta Pharmaceutica Sinica B · 被引 70)
• Upregulation of miR-125b is associated with poor prognosis and trastuzumab resistance in HER2-positive gastric cancer (2017 · Experimental and Therapeutic Medicine · 被引 45)
• Expression of Cytosolic Phospholipase A2 (cPLA2)-Arachidonic Acid (AA)-Cyclooxygenase-2 (COX-2) Pathway Factors in Lung Cancer Patients and Its Implication in Lung Cancer Early Detection and Prognosis (2019 · Medical Science Monitor · 被引 27)
• EGFR mutation L747P led to gefitinib resistance and accelerated liver metastases in a Chinese patient with lung adenocarcinoma. (2015 · PubMed · 被引 26)
• Inhibition of PLA2G4A Reduces the Expression of Lung Cancer-Related Cytokines (2018 · DNA and Cell Biology · 被引 23)